SMALL CELL LUNG CANCER LIMITED STAGE

Clinical trials for SMALL CELL LUNG CANCER LIMITED STAGE explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL LUNG CANCER LIMITED STAGE trials appear

Sign up with your email to follow new studies for SMALL CELL LUNG CANCER LIMITED STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New hope for aggressive lung cancer: can immunotherapy boost standard treatment?

Disease control Ongoing

This study is testing if adding a drug called durvalumab (an immunotherapy) to the standard treatment of chemotherapy and radiation helps people with limited-stage small cell lung cancer live longer without their cancer getting worse. About 105 participants will be randomly assig…

Matched conditions: SMALL CELL LUNG CANCER LIMITED STAGE

Phase: PHASE2 • Sponsor: Michael Hopp • Aim: Disease control

Last updated Apr 02, 2026 05:42 UTC

SMALL CELL LUNG CANCER LIMITED STAGE

Get alerted when new SMALL CELL LUNG CANCER LIMITED STAGE trials appear

New hope for aggressive lung cancer: can immunotherapy boost standard treatment?